Continuous subcutaneous insulin infusion (CSII) has become increasingly popular as a form
of intensified insulin therapy in adolescents with type 1 diabetes mellitus (DM). One reported …

OBJECTIVE: To examine the effect of continuous subcutaneous insulin infusion (CSII)
therapy on parameters affecting long-term outcome in type 1 diabetes. STUDY DESIGN …

The goal of this article was to review studies comparing continuous subcutaneous insulin
infusion (CSII) to multiple daily insulin injections (MDIs) in children and adolescents with …

Objective: To review our experience with insulin dosing during the conversion from multiple
daily injections to continuous subcutaneous insulin infusion (CSII) for children and …

The incidence of type 1 diabetes mellitus (T1DM) in young children has increased
considerably over recent years. The purpose was to examine the effectiveness and safety of …

Aims To determine the safety and effectiveness of continuous subcutaneous insulin infusion
(CSII) in attaining long‐term glycaemic control in paediatric patients with Type 1 diabetes …

Objective. The purpose of this study was to determine the feasibility of continuous
subcutaneous insulin infusion (CSII)(insulin pump) therapy in routine pediatric diabetes care …

Objective: To compare continuous subcutaneous insulin infusion (CSII) therapy with multiple
daily insulin (MDI) therapy on metabolic control in children and adolescents with type 1 …

The study assessed 3.5-year treatment with continuous subcutaneous insulin infusion (CSII)
in well-controlled children with duration of type 1 diabetes mellitus longer than 1 year …

Objective. Use of continuous subcutaneous insulin infusion (CSII) has increased
dramatically in recent years, and pump therapy has been shown to be a safe and effective …